Literature DB >> 18854674

Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis.

Fernando Holguin1, Bassel Ramadan, Anthony A Gal, Jesse Roman.   

Abstract

BACKGROUND: The objective of this study was to evaluate the factors predictive of 28-day mortality and admission to Intensive Care Unit (ICU) in patients with ANCA-related pulmonary vasculitis.
METHODS: We reviewed the medical records and imaging studies of 65 patients diagnosed with ANCA-related vasculitis hospitalized with pulmonary complications between February 1985 and November 2002. All patients underwent open or video-assisted thoracoscopic lung biopsy, had a positive ANCA serology, and were negative for glomerular basement membrane antibodies.
RESULTS: At presentation, 72% had dyspnea, 68% fever, 47% cough, 45% elevated blood pressure, 32.3% hemoptysis, 26.1% sinus involvement, 15% renal failure, and 4.6% scleritis. Pathological findings included alveolar hemorrhage (60%), granulomatous inflammation (46%), and capillaritis (38%). A significant number required mechanical ventilation (27.7%), hemodialysis (24.6%), continuous renal replacement therapy (3.1%), and plasmapheresis (3.1%). The 28-day mortality was 16.9% (11/65). Mechanical ventilation (OR 68, P < 0.005), admission to ICU (OR 18.5, P < 0.01), and blood transfusion (OR 22.4, P < 0.004) were strong predictors of increased mortality within 28 days after admission. Respiratory failure (OR 31, P < 0.0007), hemoptysis (OR 2.9, P < 0.06), smoking (OR 5.9, P < 0.02), and acute renal failure (OR 7.8, P < 0.01) were also predictors for admission to the ICU.
CONCLUSION: In patients with ANCA-related pulmonary vasculitis several clinical factors, but not pathologic findings or ANCA titers, are associated with ICU admission and/or 28-day mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854674      PMCID: PMC4411229          DOI: 10.1097/MAJ.0b013e31816805fa

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  32 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  ANCA-positive vasculitis.

Authors:  Lavanya Kamesh; Lorraine Harper; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

3.  Wegener's granulomatosis presenting as acute respiratory failure with anti-neutrophil-cytoplasm antibodies.

Authors:  C Lenclud; P De Vuyst; E Dupont; M Depierreux; P Ketelbant; M Goldman
Journal:  Chest       Date:  1989-08       Impact factor: 9.410

4.  The kidney in periarteritis nodosa.

Authors:  J DAVSON; J BALL; R PLATT
Journal:  Q J Med       Date:  1948-07

5.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

6.  A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation.

Authors:  W D Travis; T V Colby; C Lombard; H A Carpenter
Journal:  Am J Surg Pathol       Date:  1990-12       Impact factor: 6.394

Review 7.  Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management.

Authors:  R J Green; S J Ruoss; S A Kraft; S R Duncan; G J Berry; T A Raffin
Journal:  Chest       Date:  1996-11       Impact factor: 9.410

8.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  S L Hogan; P H Nachman; A S Wilkman; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

Review 9.  Microscopic polyangiitis: clinical aspects and treatment.

Authors:  F Lhote; P Cohen; T Généreau; M Gayraud; L Guillevin
Journal:  Ann Med Interne (Paris)       Date:  1996

10.  Outcome of patients with small-vessel vasculitis admitted to a medical ICU.

Authors:  S Anjum Khan; Mir Rauf Subla; Deepti Behl; Ulrich Specks; Bekele Afessa
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

View more
  12 in total

1.  Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample.

Authors:  Mavi Rivera; A Villafranca; P Khamooshi; V Reyes; J Sanchez; A Manadan
Journal:  Clin Rheumatol       Date:  2021-08-28       Impact factor: 2.980

2.  Prompt plasmapheresis successfully rescue pulmonary-renal syndrome caused by ANCA-negative microscopic polyangiitis.

Authors:  Chih-Chiang Wang; Jeng-Chuan Shiang; Ming-Kai Tsai; I-Hung Chen; Shih-Hua Lin; Pauling Chu; Chia-Chao Wu
Journal:  Clin Rheumatol       Date:  2009-08-28       Impact factor: 2.980

3.  Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.

Authors:  Mohamad Zaidan; Eric Mariotte; Lionel Galicier; Bertrand Arnulf; Véronique Meignin; Jérôme Vérine; Alfred Mahr; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2012-07-19       Impact factor: 6.925

4.  The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage.

Authors:  Kimihiko Goto; Kentaro Nakai; Hideki Fujii; Shinichi Nishi
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

5.  Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.

Authors:  Adrien Mirouse; Antoine Parrot; Vincent Audigier; Alexandre Demoule; Julien Mayaux; Guillaume Géri; Eric Mariotte; Nicolas Bréchot; Nicolas de Prost; Mathieu Vautier; Mathilde Neuville; Naïke Bigé; Etienne de Montmollin; Patrice Cacoub; Matthieu Resche-Rigon; Jacques Cadranel; David Saadoun
Journal:  Crit Care       Date:  2020-05-18       Impact factor: 9.097

6.  KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.

Authors:  Yoshiko Kida; Shinichiro Ohshimo; Kohei Ota; Tomoko Tamura; Tadatsugu Otani; Kazunobu Une; Takuma Sadamori; Yasumasa Iwasaki; Francesco Bonella; Noboru Hattori; Nobuyuki Hirohashi; Josune Guzman; Ulrich Costabel; Nobuoki Kohno; Koichi Tanigawa
Journal:  Orphanet J Rare Dis       Date:  2012-12-17       Impact factor: 4.123

7.  Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06

8.  Prognosis and ICU outcome of systemic vasculitis.

Authors:  Patrice Befort; Philippe Corne; Thomas Filleron; Boris Jung; Christian Bengler; Olivier Jonquet; Kada Klouche
Journal:  BMC Anesthesiol       Date:  2013-10-01       Impact factor: 2.217

9.  Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study.

Authors:  Antoine Kimmoun; Elisabeth Baux; Vincent Das; Nicolas Terzi; Patrice Talec; Pierre Asfar; Stephan Ehrmann; Guillaume Geri; Steven Grange; Nadia Anguel; Alexandre Demoule; Anne Sophie Moreau; Elie Azoulay; Jean-Pierre Quenot; Julie Boisramé-Helms; Guillaume Louis; Romain Sonneville; Nicolas Girerd; Nicolas Ducrocq; Nelly Agrinier; Denis Wahl; Xavier Puéchal; Bruno Levy
Journal:  Crit Care       Date:  2016-01-26       Impact factor: 9.097

10.  Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury.

Authors:  Feng Gao; Jun Fang; Falin Chen; Chengdang Wang; Shu Chen; Sheng Zhang; Xiaoting Lv; Jinchi Zhang; Qingliang He; Shaohuang Weng; Qicai Liu; Xin-Hua Lin
Journal:  EBioMedicine       Date:  2016-06-02       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.